Global Renal Diseases Drug Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Renal Diseases Drug Market Overview

• 1.1 Product Overview and Scope of Renal Diseases Drug
• 1.2 Classification of Renal Diseases Drug by Types
  • 1.2.1 Global Renal Diseases Drug Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Renal Diseases Drug Revenue Market Share by Types in 2018
  • 1.2.3 Chronic Kidney Disease (CKD) Drugs
  • 1.2.4 End-Stage Kidney Disease (ESRD) Drugs
• 1.3 Global Renal Diseases Drug Market by Application
  • 1.3.1 Global Renal Diseases Drug Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Hospitals
  • 1.3.3 Specialty Clinics
  • 1.3.4 Other
• 1.4 Global Renal Diseases Drug Market by Regions
  • 1.4.1 Global Renal Diseases Drug Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Renal Diseases Drug Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Renal Diseases Drug Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Renal Diseases Drug Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Renal Diseases Drug Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Renal Diseases Drug Status and Prospect (2014-2024)
• 1.5 Global Market Size of Renal Diseases Drug (2014-2024)

2 Company Profiles

• 2.1 Pfizer
  • 2.1.1 Business Overview
  • 2.1.2 Renal Diseases Drug Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Pfizer Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 AstraZeneca
  • 2.2.1 Business Overview
  • 2.2.2 Renal Diseases Drug Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 AstraZeneca Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 GlaxoSmithKline (GSK)
  • 2.3.1 Business Overview
  • 2.3.2 Renal Diseases Drug Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 GlaxoSmithKline (GSK) Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Amgen
  • 2.4.1 Business Overview
  • 2.4.2 Renal Diseases Drug Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Amgen Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Kissei Pharmaceutical
  • 2.5.1 Business Overview
  • 2.5.2 Renal Diseases Drug Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Kissei Pharmaceutical Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Roche
  • 2.6.1 Business Overview
  • 2.6.2 Renal Diseases Drug Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Roche Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Sanofi
  • 2.7.1 Business Overview
  • 2.7.2 Renal Diseases Drug Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Sanofi Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 AbbVie
  • 2.8.1 Business Overview
  • 2.8.2 Renal Diseases Drug Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 AbbVie Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Allergan
  • 2.9.1 Business Overview
  • 2.9.2 Renal Diseases Drug Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Allergan Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 FibroGen
  • 2.10.1 Business Overview
  • 2.10.2 Renal Diseases Drug Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 FibroGen Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Teva Pharmaceutical Industries
  • 2.11.1 Business Overview
  • 2.11.2 Renal Diseases Drug Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Teva Pharmaceutical Industries Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Johnson & Johnson
  • 2.12.1 Business Overview
  • 2.12.2 Renal Diseases Drug Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Johnson & Johnson Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)
• 2.13 Keryx Biopharmaceuticals
  • 2.13.1 Business Overview
  • 2.13.2 Renal Diseases Drug Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Keryx Biopharmaceuticals Renal Diseases Drug Revenue, Gross Margin and Market Share (2017-2018)

3 Global Renal Diseases Drug Market Competition, by Players

• 3.1 Global Renal Diseases Drug Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Renal Diseases Drug Players Market Share
  • 3.2.2 Top 10 Renal Diseases Drug Players Market Share
• 3.3 Market Competition Trend

4 Global Renal Diseases Drug Market Size by Regions

• 4.1 Global Renal Diseases Drug Revenue and Market Share by Regions
• 4.2 North America Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 4.3 Europe Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 4.5 South America Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Renal Diseases Drug Revenue and Growth Rate (2014-2019)

5 North America Renal Diseases Drug Revenue by Countries

• 5.1 North America Renal Diseases Drug Revenue by Countries (2014-2019)
• 5.2 USA Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 5.3 Canada Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Renal Diseases Drug Revenue and Growth Rate (2014-2019)

6 Europe Renal Diseases Drug Revenue by Countries

• 6.1 Europe Renal Diseases Drug Revenue by Countries (2014-2019)
• 6.2 Germany Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 6.3 UK Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 6.4 France Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 6.5 Russia Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 6.6 Italy Renal Diseases Drug Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Renal Diseases Drug Revenue by Countries

• 7.1 Asia-Pacific Renal Diseases Drug Revenue by Countries (2014-2019)
• 7.2 China Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 7.3 Japan Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 7.4 Korea Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 7.5 India Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Renal Diseases Drug Revenue and Growth Rate (2014-2019)

8 South America Renal Diseases Drug Revenue by Countries

• 8.1 South America Renal Diseases Drug Revenue by Countries (2014-2019)
• 8.2 Brazil Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Renal Diseases Drug Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Renal Diseases Drug by Countries

• 9.1 Middle East and Africa Renal Diseases Drug Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 9.3 UAE Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Renal Diseases Drug Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Renal Diseases Drug Revenue and Growth Rate (2014-2019)

10 Global Renal Diseases Drug Market Segment by Type

• 10.1 Global Renal Diseases Drug Revenue and Market Share by Type (2014-2019)
• 10.2 Global Renal Diseases Drug Market Forecast by Type (2019-2024)
• 10.3 Chronic Kidney Disease (CKD) Drugs Revenue Growth Rate (2014-2024)
• 10.4 End-Stage Kidney Disease (ESRD) Drugs Revenue Growth Rate (2014-2024)

11 Global Renal Diseases Drug Market Segment by Application

• 11.1 Global Renal Diseases Drug Revenue Market Share by Application (2014-2019)
• 11.2 Renal Diseases Drug Market Forecast by Application (2019-2024)
• 11.3 Hospitals Revenue Growth (2014-2019)
• 11.4 Specialty Clinics Revenue Growth (2014-2019)
• 11.5 Other Revenue Growth (2014-2019)

12 Global Renal Diseases Drug Market Size Forecast (2019-2024)

• 12.1 Global Renal Diseases Drug Market Size Forecast (2019-2024)
• 12.2 Global Renal Diseases Drug Market Forecast by Regions (2019-2024)
• 12.3 North America Renal Diseases Drug Revenue Market Forecast (2019-2024)
• 12.4 Europe Renal Diseases Drug Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Renal Diseases Drug Revenue Market Forecast (2019-2024)
• 12.6 South America Renal Diseases Drug Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Renal Diseases Drug Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology